EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications

Yaling Yin, Linyu Wei, Emily A Caseley, Osbaldo Lopez-Charcas iD, Yingjuan Wei, Dongliang Li, Steve P Muench, Sebastian Roger, Lu Wang, Lin-Hua Jiang iD

Medicinal Research Reviews · 2023

DOI: 10.1002/med.21952 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2023. Verfasst von Yaling Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, X…. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Central Nervous System. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The P2X7 receptor is an exceptional member of the P2X purinergic receptor family, with its activation requiring high concentrations of extracellular adenosine 5ʹ‐triphosphate (ATP) that are often associated with tissue damage and inflammation. In the central nervous system (CNS), it is highly expressed in glial cells, particularly in microglia. In this review, we discuss the role and mechanisms of the P2X7 receptor in mediating neuroinflammation and other pathogenic events in a variety of traumatic CNS damage conditions, which lead to loss of neurological and cognitive functions. We raise the perspective on the steady progress in developing CNS‐penetrant P2X7 receptor‐specific antagonists that leverage the ATP‐P2X7 receptor signaling axis as a potential therapeutic strategy to alleviate traumatic CNS damage and related complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Purinergic P2X7Central Nervous SystemHumansMicrogliaPurinergic P2X Receptor AntagonistsAdenosine Triphosphate

Stichwörter der Autor:innen

CNS-penetrant P2X7 receptor antagonistP2X7 receptorextracellular ATPmicroglial activationneuroinflammationproinflammatory cytokinetherapeuticstraumatic CNS damage

Substanzen

Receptors, Purinergic P2X7Purinergic P2X Receptor AntagonistsAdenosine Triphosphate

Autor:innen und Institutionen

  • Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, Xinxiang, China.
  • Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, UK.
  • EA4245, Transplantation, Immunology and Inflammation, Faculty of Medicine, University of Tours, Tours, France.
  • Sanquan College of Xinxiang Medical University, Xinxiang, China.

ORCID-Profile: Osbaldo Lopez-Charcas, Lin-Hua Jiang

Förderung

  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Yin, Y., Wei, L., Caseley, E. A., Lopez-Charcas, O., Wei, Y., Li, D., Muench, S. P., Roger, S., Wang, L., & Jiang, L. H. (2023). Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications. Medicinal Research Reviews. https://doi.org/10.1002/med.21952

Vancouver

Yin Y, Wei L, Caseley EA, Lopez-Charcas O, Wei Y, Li D, et al. Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications. Medicinal Research Reviews. 2023. doi:10.1002/med.21952

BibTeX
@article{Yin2023,
  author = {Yin, Yaling and Wei, Linyu and Caseley, Emily A and Lopez-Charcas, Osbaldo and Wei, Yingjuan and Li, Dongliang and Muench, Steve P and Roger, Sebastian and Wang, Lu and Jiang, Lin-Hua},
  title = {Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications},
  journal = {Medicinal Research Reviews},
  year = {2023},
  doi = {10.1002/med.21952}
}
Kostenlos starten →